Alexander Mackenzie

Track

Insider profile

Currently holds a position at Pfizer Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, Chief Development Officer Pfizer Inc June 1, 2016 -
Alexander Mackenzie's trades of Pfizer Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Pfizer Inc (PFE)
Transaction date
Sale
Price
320.43
Quantity 33,277 +20.6%
Value US$1,884,572
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
320.88
Quantity 79,440 +4.9%
Value US$2,046,234
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
201.08
Quantity 50,918 +1.6%
Value US$3,562,445
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.90
Quantity 1,581 -1.4%
Value US$67,825
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.80
Quantity 1,230 -1.1%
Value US$52,644
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.85
Quantity 1,134 -1.0%
Value US$48,592
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.82
Quantity 1,100 -0.9%
Value US$47,102
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.79
Quantity 800 -0.7%
Value US$34,232
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.84
Quantity 713 -0.6%
Value US$30,545
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.81
Quantity 703 -0.6%
Value US$30,095
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.83
Quantity 658 -0.5%
Value US$28,182
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.91
Quantity 623 -0.5%
Value US$26,733
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.76
Quantity 600 -0.5%
Value US$25,656
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.77
Quantity 600 -0.5%
Value US$25,662
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.89
Quantity 560 -0.5%
Value US$24,018
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.87
Quantity 555 -0.5%
Value US$23,793
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.86
Quantity 547 -0.4%
Value US$23,444
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.78
Quantity 300 -0.2%
Value US$12,834
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.67
Quantity 294 -0.2%
Value US$12,545
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.59
Quantity 200 -0.2%
Value US$8,518
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.92
Quantity 152 -0.1%
Value US$6,524
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.60
Quantity 128 -0.1%
Value US$5,453
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.61
Quantity 107 -0.1%
Value US$4,559
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.74
Quantity 100 -0.1%
Value US$4,274
US Pfizer Inc (PFE)
Transaction date
Planned sale
Price
42.93
Quantity 100 -0.1%
Value US$4,293
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-06 2021-12-02
US Pfizer Inc (PFE)
S Sale
33,277 +20.6%
320.43
US$1,884,572 		33,277 +20.6% 320.43 US$1,884,572
2019-06-21 2019-06-20
US Pfizer Inc (PFE)
PlS Planned sale
79,440 +4.9%
320.88
US$2,046,234 		79,440 +4.9% 320.88 US$2,046,234
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
50,918 +1.6%
201.08
US$3,562,445 		50,918 +1.6% 201.08 US$3,562,445
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
1,581 -1.4%
42.90
US$67,825 		1,581 -1.4% 42.90 US$67,825
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
1,230 -1.1%
42.80
US$52,644 		1,230 -1.1% 42.80 US$52,644
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
1,134 -1.0%
42.85
US$48,592 		1,134 -1.0% 42.85 US$48,592
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
1,100 -0.9%
42.82
US$47,102 		1,100 -0.9% 42.82 US$47,102
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
800 -0.7%
42.79
US$34,232 		800 -0.7% 42.79 US$34,232
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
713 -0.6%
42.84
US$30,545 		713 -0.6% 42.84 US$30,545
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
703 -0.6%
42.81
US$30,095 		703 -0.6% 42.81 US$30,095
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
658 -0.5%
42.83
US$28,182 		658 -0.5% 42.83 US$28,182
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
623 -0.5%
42.91
US$26,733 		623 -0.5% 42.91 US$26,733
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
600 -0.5%
42.76
US$25,656 		600 -0.5% 42.76 US$25,656
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
600 -0.5%
42.77
US$25,662 		600 -0.5% 42.77 US$25,662
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
560 -0.5%
42.89
US$24,018 		560 -0.5% 42.89 US$24,018
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
555 -0.5%
42.87
US$23,793 		555 -0.5% 42.87 US$23,793
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
547 -0.4%
42.86
US$23,444 		547 -0.4% 42.86 US$23,444
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
300 -0.2%
42.78
US$12,834 		300 -0.2% 42.78 US$12,834
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
294 -0.2%
42.67
US$12,545 		294 -0.2% 42.67 US$12,545
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
200 -0.2%
42.59
US$8,518 		200 -0.2% 42.59 US$8,518
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
152 -0.1%
42.92
US$6,524 		152 -0.1% 42.92 US$6,524
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
128 -0.1%
42.60
US$5,453 		128 -0.1% 42.60 US$5,453
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
107 -0.1%
42.61
US$4,559 		107 -0.1% 42.61 US$4,559
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
100 -0.1%
42.74
US$4,274 		100 -0.1% 42.74 US$4,274
2019-04-02 2019-04-01
US Pfizer Inc (PFE)
PlS Planned sale
100 -0.1%
42.93
US$4,293 		100 -0.1% 42.93 US$4,293